Moscow, Russia

Gennadi G Chichkanov

This inventor holds 1 USPTO granted patent. Top assignee: Arzneimittelwerk Dresden Gmbh. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gennadi G Chichkanov. Retrieved from https://idiyas.com/inventor/gennadi-g-chichkanov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gennadi G Chichkanov: Innovator in Antiarrhythmic Treatments

Introduction

Gennadi G Chichkanov is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for antiarrhythmia. His innovative work has led to the creation of a unique patent that addresses critical health issues.

Latest Patents

Gennadi holds a patent for 5-(1-aminoacyl)-5,10-dihydro-11H-dibenzo[b,e](1,4)diazepin-11-ones. This patent also includes 5-(w-Aminoacyl)-5,10-dihydro-11H-dibenzo(b,e)(1,4)-diazepine-11-ones and their preparation methods. These compounds are disclosed for their potential use in treating antiarrhythmia and as anticholinergic drugs. Gennadi's patent portfolio includes 1 patent.

Career Highlights

Gennadi is currently associated with Arzneimittelwerk Dresden GmbH, where he continues to advance his research and development efforts. His work is characterized by a commitment to improving patient outcomes through innovative drug formulations.

Collaborations

Gennadi has collaborated with esteemed colleagues such as Carla Ruger and Wolfgang Sauer. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Gennadi G Chichkanov is a prominent figure in the pharmaceutical industry, recognized for his innovative contributions to antiarrhythmic treatments. His work exemplifies the impact of dedicated research and collaboration in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…